Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 41 entries
View as:

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06091579 Org: User:
Start: 09/17/20 End: 01/12/21 Due: 01/12/22

Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase

Phase: N/A Priority: Normal
NCT ID: NCT03905642 Org: User:
Start: 01/08/09 End: 11/02/10 Due: 11/02/11

A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05517525 Org: User:
Start: 10/04/22 End: 06/01/23 Due: 06/01/24

A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05673603 Org: User:
Start: 07/20/21 End: 02/14/23 Due: 02/14/24

A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

Phase: N/A Priority: Normal
NCT ID: NCT06685835 Org: User:
Start: 12/16/24 End: 01/28/27 Due: 01/28/28

Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection

Phase: N/A Priority: Normal
NCT ID: NCT01316276 Org: User:
Start: 10/05/12 End: 07/16/15 Due: 07/16/16

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT03218917 Org: User:
Start: 10/31/17 End: 12/12/19 Due: 12/12/20

Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Phase: N/A Priority: Normal
NCT ID: NCT04677569 Org: User:
Start: 04/01/21 End: 01/15/26 Due: 01/15/27

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Phase: N/A Priority: Normal
NCT ID: NCT05649722 Org: User:
Start: 05/11/23 End: 03/14/26 Due: 03/14/27

A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Phase: N/A Priority: Normal
NCT ID: NCT06013241 Org: User:
Start: 10/30/23 End: 09/25/25 Due: 09/25/26

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Phase: N/A Priority: Normal
NCT ID: NCT01315678 Org: User:
Start: 02/29/12 End: 09/18/13 Due: 09/18/14

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT05090904 Org: User:
Start: 11/30/21 End: 11/01/22 Due: 11/01/23

A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05355935 Org: User:
Start: 04/27/22 End: 10/07/22 Due: 10/07/23

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT05649748 Org: User:
Start: 03/07/23 End: 12/31/26 Due: 12/31/27

An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Phase: N/A Priority: Normal
NCT ID: NCT06939647 Org: User:
Start: - End: - Due: -

IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00368173 Org: User:
Start: - End: - Due: -

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Phase: N/A Priority: Normal
NCT ID: NCT00558844 Org: User:
Start: 01/31/08 End: 06/30/09 Due: 06/30/10

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

Phase: N/A Priority: Normal
NCT ID: NCT00775138 Org: User:
Start: 06/24/08 End: 05/11/09 Due: 05/11/10

A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06178783 Org: User:
Start: 12/27/23 End: 01/04/24 Due: 01/04/25

A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05965570 Org: User:
Start: 07/28/23 End: 09/22/23 Due: 09/22/24

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Phase: N/A Priority: Normal
NCT ID: NCT00577577 Org: User:
Start: 12/31/07 End: 12/29/08 Due: 12/29/09

Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone

Phase: N/A Priority: Normal
NCT ID: NCT02344004 Org: User:
Start: 05/27/15 End: 04/03/19 Due: 04/03/20

A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT04791514 Org: User:
Start: 03/29/22 End: 08/26/22 Due: 08/26/23

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06193031 Org: User:
Start: 11/17/15 End: 12/18/15 Due: 12/18/16

An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT05344508 Org: User:
Start: - End: - Due: -